Ping An Health Posts 2025 Net Profit of RMB 379.51 Million on 13.7% Revenue Growth

Bulletin Express
03/24

PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED (“Ping An Health”) reported audited results for the year ended 31 December 2025.

Financial Highlights • Revenue rose 13.7% year on year to RMB 5.47 billion, driven by stronger insurance enablement and corporate health management. • Gross profit increased 16.3% to RMB 1.77 billion; gross margin improved 0.7 percentage points to 32.4%. • Profit attributable to owners of the parent reached RMB 379.51 million versus RMB 81.43 million in 2024. • Adjusted net profit (non-IFRS) was RMB 414.0 million, up 161.3%. • Total expenses-to-revenue ratio fell 4.6 percentage points to 30.6%.

Revenue Breakdown • Commercial insurance enablement: RMB 3.30 billion, +11.0%. • Corporate health management: RMB 1.31 billion, +40.6%; share of total revenue expanded to 23.9%. • Other revenue: RMB 0.87 billion, –4.8%.

Operational Highlights • Paying users neared 35 million, up 11.4%. • Corporate client base reached 6,700+, an 83.1% increase. • Service network covered 5,100+ hospitals, 240,000+ pharmacies and 4,400+ health-check providers. • AI-driven services served nearly 12 million users; AI contributed about 4.5% of group gross profit.

Cost & Efficiency • Selling and marketing expenses rose 8.6% to RMB 828.92 million but fell to 15.2% of revenue (–0.7 ppt). • Administrative expenses declined 9.1% to RMB 845.75 million, or 15.5% of revenue (–3.9 ppt).

Financial Position • Total assets: RMB 13.23 billion; net assets: RMB 9.91 billion at end-2025. • Total available funds (cash, restricted cash, term deposits, financial assets): RMB 9.63 billion. • Gearing ratio stood at 25.13%.

Dividend • No dividend was declared for 2025.

Strategic Focus Ping An Health will deepen “insurance + healthcare” synergies with Ping An Group, accelerate AI deployment across medical scenarios, and expand corporate health solutions while enhancing its “online, in-hospital, in-home, in-company” service network.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10